法尼酯衍生物X受体在梗阻性黄疸中的作用及分子机制的研究进展
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Role and molecular mechanism of farnesoid X receptor in obstructive jaundice
  • 作者:谭用 ; 毕伟 ; 张桂信
  • 英文作者:Yong Tan;Wei Bi;Gui-Xin Zhang;Department of General Surgery, the First Affiliated Hospital of Dalian Medical University;Graduate School, Dalian Medical University;
  • 关键词:胆汁酸 ; 法尼酯衍生物X受体 ; 梗阻性黄疸
  • 英文关键词:Bile acid;;Farnesoid X receptor;;Obstructive jaundice
  • 中文刊名:XXHB
  • 英文刊名:World Chinese Journal of Digestology
  • 机构:大连医科大学附属第一医院腹部急症外科;大连医科大学研究生院;
  • 出版日期:2015-06-08
  • 出版单位:世界华人消化杂志
  • 年:2015
  • 期:v.23;No.492
  • 基金:国家自然科学基金青年基金资助项目,No.81303110;; 国家教育部博士学科点专项科研基金资助项目,No.20112105120007~~
  • 语种:中文;
  • 页:XXHB201516013
  • 页数:8
  • CN:16
  • 分类号:69-76
摘要
梗阻性黄疸是临床常见病和多发病,严重时可因胆汁酸淤积入血而造成多脏器功能障碍.法尼酯衍生物X受体(farnesoid X receptor,F X R)是胆汁酸的核受体,在胆汁酸代谢中起到重要作用.近年来研究证明,F X R还参与梗阻性黄疸时对机体功能和病理损伤的调节.本文综述FXR在梗阻性黄疸中的作用和分子机制的最新研究进展,以期为梗阻性黄疸的治疗探索新的方法和途径.
        Obstructive jaundice is a common and frequently occurring disease,which can result in multiple organ dysfunction syndrome in serious conditions due to the abnormal accumulation of bile acids in blood.Farnesoid X receptor(FXR),a nuclear receptor for bile acid,plays a significant role in bile acid metabolism.Recent research demonstrates that FXR also participates in the regulation of the pathological and physiological processes during obstructive jaundice.In this article,we review the latest research about the role and molecular mechanism of FXR in obstructive jaundice,in order to explore new methods and strategies for curing the disease.
引文
1 Krawczyk M,Grunhage F,Langhirt M,Bohle RM,Lammert F.Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters.Ann Hepatol 2012;11:710-714[PMID:22947535]
    2 Ali AH,Carey EJ,Lindor KD.Recent advances in the development of farnesoid X receptor agonists.Ann Transl Med 2015;3:5[PMID:25705637 DOI:10.3978/j.issn.2305-5839.2014.12.06]
    3 Chiang JY.Bile acid regulation of gene expression:roles of nuclear hormone receptors.Endocr Rev2002;23:443-463[PMID:12202460 DOI:10.1210/er.2000-0035]
    4 Seol W,Choi HS,Moore DD.Isolation of proteins that interact specifically with the retinoid X receptor:two novel orphan receptors.Mol Endocrinol 1995;9:72-85[PMID:7760852 DOI:10.1210/mend.9.1.7760852]
    5 Lefebvre P,Cariou B,Lien F,Kuipers F,Staels B.Role of bile acids and bile acid receptors in metabolic regulation.Physiol Rev 2009;89:147-191[PMID:19126757 DOI:10.1152/physrev.00010.2008]
    6 Forman BM,Goode E,Chen J,Oro AE,Bradley DJ,Perlmann T,Noonan DJ,Burka LT,McMorris T,Lamph WW,Evans RM,Weinberger C.Identification of a nuclear receptor that is activated by farnesol metabolites.Cell 1995;81:687-693[PMID:7774010 DOI:10.1016/0092-8674195190530-8]
    7 Zhang Y,Kast-Woelbern HR,Edwards PA.Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation.J Biol Chent 2003;278:104-110[PMID:12393883 DOI:10.1074/jbc.M209505200]
    8 Makishima M,Okamoto AY,Repa JJ,Tu H,Learned RM,Luk A,Hull MV,Lustig KD,Mangelsdorf DJ,Shan B.Identification of a nuclear receptor for bile acids.Science 1999;284:1362-1365[PMID:10334992 DOI:10.1126/science.284.5418.1362]
    9 Lew JL,Zhao A,Yu J,Huang L,De Pedro N,Pelaez F,Wright SD,Cui J.The farnesoid X receptor controls gene expression in a ligandand promoter-selective fashion.J Biol Chent2004;279:8856-8861[PMID:14684751 DOI:10.1007/1-4020-2913-6_8]
    10 Lee FY,Lee H,Hubbert ML,Edwards PA,Zhang Y.FXR,a multipurpose nuclear receptor.Trends Biochem Sci 2006;31:572-580[PMID:16908160DOI:10.1016/j.tibs.2006.08.002]
    11 Shen H,Zhang Y,Ding H,Wang X,Chen L,Jiang H,Shen X.Farnesoid X receptor induces GLUT4expression through FXR response element in the GLUT4 promoter.Cell Physiol Biochem 2008;22:1-14[PMID:18769028 DOI:10.1159/000149779]
    12 Yu J,Lo JL,Huang L,Zhao A,Metzger E,Adams A,Meinke PT,Wright SD,Cui J.Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.J Biol Chent 2002;277:31441-31447[PMID:12052824DOI:10.1074/jbc.M200474200]
    13 Hoeke MO,Heegsma J,Hoekstra M,Moshage H,Faber KN.Human FXR regulates SHP expression through direct binding to an LRH-1 binding site,independent of an IR-1 and LRH-1.PLoS One2014;9:e88011[PMID:24498423 DOI:10.1371/journal.pone.0088011]
    14 Jonker JW,Liddle C,Downes M.FXR and PXR:potential therapeutic targets in cholestasis.J Steroid Biochem Mol Biol 2012;130:147-158[PMID:21801835 DOI:10.1016/j.jsbmb.2011.06.012]
    15 Sinai CJ,Tohkin M,Miyata M,Ward JM,Lambert G,Gonzalez FJ.Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.Cell 2000;102:731-744[PMID:11030617 DOI:10.1016/S0092-8674(00)00062-3]
    16 Chiang JY,Kimmel R,Weinberger C,Stroup D.Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene(CYP7A1)transcription.J Biol Chem 2000;275:10918-10924[PMID:10753890 DOI:10.1074/jbc.275.15.10918]
    17 De Fabiani E,Mitro N,Anzulovich AC,Pinelli A,Galli G,Crestani M.The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene(CYP7A1)converge to hepatic nuclear factor-4:a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors.J Biol Chem 2001;276:30708-30716[PMID:11402042 DOI:10.1074/jbc.M103270200]
    18 Kerr TA,Saeki S,Schneider M,Schaefer K,Berdy S,Redder T,Shan B,Russell DW,Schwarz M.Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.Dev Cell 2002;2:713-720[PMID:12062084 DOI:10.1016/s1534-5807(02)00154-5]
    19 Boulias K,Katrakili N,Bamberg K,Underhill P,Greenfield A,Talianidis I.Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.EMBO J 2005;24:2624-2633[PMID:15973435 DOI:10.1038/sj.emboj.7600728]
    20 Inagaki T,Choi M,Moschetta A,Peng L,Cummins CL,McDonald JG,Luo G,Jones SA,Goodwin B,Richardson JA,Gerard RD,Repa JJ,Mangelsdorf DJ,Kliewer SA.Fibroblast growth factor 15functions as an enterohepatic signal to regulate bile acid homeostasis.Cell Metab 2005;2:217-225[PMID:16213224 DOI:10.1016/j.cmet.2005.09.001]
    21 Holt JA,Luo G,Billin AN,Bisi J,McNeill YY,Kozarsky KF,Donahee M,Wang DY,Mansfield TA,Kliewer SA,Goodwin B,Jones SA.Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.Genes Dev 2003;17:1581-1591[PMID:12815072 DOI:10.1101/gad.1083503]
    22 Miao J,Xiao Z,Kanamaluru D,Min G,Yau PM,Veenstra TD,Ellis E,Strom S,Suino-Powell K,Xu HE,Kemper JK.Bile acid signaling pathways increase stability of Small Heterodimer Partner(SHP)by inhibiting ubiquitin-proteasomal degradation.Genes Dev 2009;23:986-996[PMID:19390091 DOI:10.1101/gad.1773909]
    23 Garzel B,Yang H,Zhang L,Huang SM,Polli JE,Wang H.The role of bile salt export pump gene repression in drug-induced cholestatic liver toxidty.Drug Metab Dispos 2014;42:318-322[PMID:24335466 DOI:10.1124/dmd.113.054189]
    24 Ananthanarayanan M,Balasubramanian N,Makishima M,Mangelsdorf DJ,Suchy FJ.Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.J Biol Chent 2001;276:28857-28865[PMID:11387316DOI:10.1074/jbc.Moll610200]
    25 Matsubara T,Li F,Gonzalez FJ.FXR signaling in the enterohepatic system.Mol Cell Endocrinol2013;368:17-29[PMID:22609541 DOI:10.1016/j.mce.2012.05.004]
    26 Sinha J,Chen F,Miloh T,Burns RC,Yu Z,Shneider BL.beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes.Am J Physiol Gastrointest Liver Physiol 2008;295:G996-G1003[PMID:18772362 DOI:10.1152/ajpgi.90343.2008]
    27 Boyer JL,Trauner M,Mennone A,Soroka CJ,Cai SY,Moustafa T,Zollner G,Lee JY,Ballatori N.Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.Am]Physiol Gastrointest Liver Physiol 2006;290:G1124-G1130[PMID:16423920 DOI:10.1152/ajpgi.00539.2005]
    28 Fiorucci S,Distrutti E,Ricd P,Giuliano V,Donini A,Baldelli F.Targeting FXR in cholestasis:hype or hope.Expert Opin Ther Targets 2014;18:1449-1459[PMID:25200104 DOI:10.1517/14728222.2014.956087]
    29 Alvelius G,Hjalmarson O,Griffiths WJ,Bjorkhem I,Sjovall J.Identification of unusual 7-oxygenated bile acid sulfates in a patient with Niemann-Pick disease,type C.J Lipid Res 2001;42:1571-1577[PMID:11590212]
    30Denson LA,Sturm E,Echevarria W,Zimmerman TL,Makishima M,Mangelsdorf DJ,Karpen SJ.The orphan nuclear receptor,shp,mediates bile acidinduced inhibition of the rat bile acid transporter,ntcp.Gastroenterology 2001;121:140-147[PMID:11438503 DOI:10.1053/gast.2001.25503]
    31 Mae da T,Miyata M,Yotsumoto T,Kobayashi D,Nozawa T,Toyama K,Gonzalez FJ,Yamazoe Y,Tamai I.Regulation of drug transporters by the farnesoid X receptor in mice.Mol Pharnt2004;1:281-289[PMID:15981587 DOI:10.1021/mp0499656]
    32 Eloranta JJ,Jung D,Kullak-Ublick GA.The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptorgamma coactivator-lalpha,and suppressed by bile acids via a small heterodimer partner-dependent mechanism.Mol Endocrinol 2006;20:65-79[PMID:16123152 DOI:10.1210/me.2005-0159]
    33吴晓平,柴进,陈文生.阻塞性胆汁淤积大鼠肝脏胆固醇7α-经化酶和核受体FXR、SHP表达变化.第二军医大学学报2009;12:1398-1401
    34 Liu Y,Binz J,Numerick MJ,Dennis S,Luo G,Desai B,MacKenzie KI,Mansfield TA,Kliewer SA,Goodwin B,Jones SA.Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra-and extrahepatic cholestasis.J Clin Invest 2003;112:1678-1687[PMID:14623915 DOI:10.1172/JCI200318945]
    35 Lee FY,Kast-Woelbern HR,Chang J,Luo G,Jones SA,Fishbein MC,Edwards PA.Alpha-crystallin is a target gene of the farnesoid X-activated receptor in human livers.J Bid Chem 2005;280:31792-31800[PMID:16012168 DOI:10.1074/jbc.M503182200]
    36 Guo GL,Lambert G,Negishi M,Ward JM,Brewer HB,Kliewer SA,Gonzalez FJ,Sinai CJ.Complementary roles of farnesoid X receptor,pregnane X receptor,and constitutive androstane receptor in protection against bile acid toxidty.J Biol Chem 2003;278:45062-45071[PMID:12923173DOI:10.1074/jbc.M307145200]
    37 Yang F,Huang X,Yi T,Yen Y,Moore DD,Huang W.Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.Cancer Res 2007;67:863-867[PMID:17283114 DOI:10.1158/0008-5472.CAN-06-1078]
    38 Wang YD,Yang F,Chen WD,Huang X,Lai L,Forman BM,Huang W.Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.Mol Endocrinol 2008;22:1622-1632[PMID:18436567DOI:10.1210/me.2007-0527]
    39 Schuppan D,Popov Y.Hepatic fibrosis:from bench to bedside.J Gastroenterol Hepatol 2002;17Suppl 3:S300-S305[PMID:12472954 DOI:10.1046/j.1440-1746,17,s3,18.X]
    40 Chen WD,Wang YD,Zhang L,Shiah S,Wang M,Yang F,Yu D,Forman BM,Huang W.Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.Hepatology2010;51:953-962[PMID:19998409 DOI:10.1002/hep.23390]
    41 Fausther M,Dranoff JA.New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice.J Hepatol 2011;55:939-940[PMID:21672564 DOI:10.1016/j.jhep.2011.04.013]
    42 Fiorucci S,Antonelli E,Rizzo G,Renga B,Mencarelli A,Riccardi L,Orlandi S,Pellicdari R,Morelli A.The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.Gastroenterology 2004;127:1497-1512[PMID:15521018 DOI:10.1053/j.gastro.2004.08.001]
    43 Huang W,Ma K,Zhang J,Qatanani M,Cuvillier J,Liu J,Dong B,Huang X,Moore DD.Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.Science 2006;312:233-236[PMID:16614213 DOI:10.1126/sdence.1121435]
    44 Chen WD,Wang YD,Meng Z,Zhang L,Huang W.Nuclear bile acid receptor FXR in the hepatic regeneration.Biochint Biophys Acta 2011;1812:888-892[PMID:21167938 DOI:10.1016/j.bbadis.2010.12.006]
    45 Lorenzo-Zuniga V,Bartoli R,Planas R,Hofmann AF,Vinado B,Hagey LR,Hernandez JM,Man6J,Alvarez MA,Ausina V,Gassull MA.Oral bile acids reduce bacterial overgrowth,bacterial translocation,and endotoxemia in cirrhotic rats.Hepatology 2003;37:551-557[PMID:12601352 DOI:10.1053/jhep.2003.50116]
    46 Inagaki T,Moschetta A,Lee YK,Peng L,Zhao G,Dowries M,Yu RT,Shelton JM,Richardson JA,Repa JJ,Mangelsdorf DJ,KKewer SA.Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.Proc Natl Acad Sci USA 2006;103:3920-3925[PMID:16473946 DOI:10.1073/pnas.0509592103]
    47 Mankertz J,Tavalali S,Schmitz H,Mankertz A,Riecken EO,Fromm M,Schulzke JD.Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma.J Cell Sci 2000;113(Pt 11):2085-2090[PMID:10806119]
    48 Assimakopoulos SF,Scopa CD,Charonis A,Spiliopoulou I,Georgiou C,Nikolopoulou V,Vagianos CE.Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression:beneficial effect of bombesin and neurotensin.J Am Coll Surg 2004;198:748-757[PMID:15110809 DOI:10.1016/j.jamcollsurg.2003.12.017]
    49 D'Aldebert E,Biyeyeme Bi Mve MJ,Mergey M,Wendum D,Firrincieli D,Coilly A,Fouassier L,Corpechot C,Poupon R,Housset C,Chignard N.Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium.Gastroenterology 2009;136:1435-1443[PMID:19245866 DOI:10.1053/j.gastro.2008.12.040]
    50 Wu L,Li W,Wang Z,Yuan Z,Hyder Q.Bile acidinduced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction.Scand J Gastroenterol 2013;48:496-503[PMID:23410061DOI:10.3109/00365521.2013.763173]
    51黄伟炜,郑进方,宫晓光,王保春,伍海鹰,刘宁.阻塞性黄疸大鼠肝脏中法尼酯衍生物X受体的表达及CDCA对其影响.海南医学2012;22:1003-6350
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.